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The Human Genome Project and the courts

The courts will be called upon
to settle an array of disputes
involving genetic medicine among patients,
health care professionals, insurers,
and the government.
'
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--,_,,~he impact of the Human

Genome Project will be
much broader than just
making it possible to test
people or to screen populations for
genetic disorders. Gene therapies-both in the form of drugs
manufactured with genetic techno!MAXWELL J. MEHLMAN is Arthur E.
Petersilge Professor of Law and director,
The Law-Medicine Center, Case Western
Reserve University School of Law, and
Professor of Biomedical Ethics, Case
Western Reserve University School of
Medicine.

ogy and gene transfer involving the
actual manipulation of cellular
DNA-will usher in a new era of genetic medicine.
Gene therapy already is a reality.
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Hundreds of clinical trials are underway to test the safety and
efficacy of gene therapy to treat disorders such as cystic fibrosis and
Parkinson's disease. 1
So far, these new technologies are
limited to producing so-called "somatic" effects in patients-that is,
effects that do not alter reproducThis article was written under a grant from the
Ethical, Legal, and Social Implications Research
Program, Human Genome Research Institute,
National Institutes of Health (No. I ROI
HGOJ446-0IAI). The author thanks Senia
Pickering for her exceptional research help.
I. See McLachlan, Ho, Davidson-Smith,
Sam ways, Davidson, Stevenson, Carothers, Alton,
Middleton, Smith, Kallmeyer, Michaelis, Seeber,
Naujoks, Greening, Innes, Dorin, and Porteou,
LaboratOI)' and clinical studies in support of cystic ji&rosis gene therap_v using pCMV-CFTR-DOT:!P, 3
GENE THER. lJ 13-1123 (1996); Colledge, Cystic fibrosis Gene Therapy, 4 CuR. OPIN. GENET. DEv. 466471 (1994); McElvaney, Is gene therapy in cystic fibrosis a realistit:-exfJectation?, 2 CuRR. 0PIN. Puu.I.

MEO. 466-471 (!996).

tive cells and therefore that would
not be passed on to the patient's
offspring. But studies have been
proposed in which genetic manipulations would change the DNA inside eggs or sperm. 2 These so-called
2. Cooke, Pushing the Human Limit: Gene
Therap_v That Could Affect Future Generations Too,
NEwsow, August 3D, 1990, atA6.
.3. See Recombinant DNA Advisory Committee,
Discussion Regarding the Use of Normal Subjects m Human Gene Transfer Clinical Trials,
lV!~rch 6_-7, 1997, pg. 2 (in author's possession)
(dlscussmg protocol to characterize local, systemic a':'d distant compartment immunity in normalmdn~duals after intradermal administration
?fa replication deficient AdS-based vector carryIng gene coding for the E. coli enzyme, cytosine
adenase).

germ line gene therapies" intraduce the possibility of eliminating
genetically-related diseases in succeeding generations.
The future holds the prospect of
even more da1ing genetic manipulations. The Human Genome Project
will provide scientists with the data
and tools to identify and understand
the basis of genetic diseases and disorders, as well as other geneticallyrelated traits. This creates the possibility of genetic interventions to
enhance non-disease traits, for example, to increase strength, stamina,
and perhaps even intelligence. Nor
November-December 1999

are these enhancement technologies
just in the realm of science fiction.
Scientists have begun to use gene
transfer technologies to enhance the
immune systems of advanced cancer
and HIV-infected patients, and they
are experimentally transferring "foreign" genes (i.e., not one's own) into
healthy subjects in search of new
mechanisms to deliver gene therapies to patients. 3
These new technologies will create
a host of difficult, often unprecedented, ethical and legal controversies, many of which will find their way
to the courts for resolution.
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patients at risk for genetic ailments
about the benefits and risks of new
genetic technologies. Not only will
they have to inform and advise patients about the complex matrix of
individual genetic risk factors revealed by an expanding array of genetic tests, and to help patients compare the medical benefits and risks of
various gene therapies and alternative treatments; they also will be the
primary source of patient information about the non-medical costs of
accessing genetic technologies, including the risks of insurance and
employment discrimination.

Beyond gene therapy
As mentioned at the outset of this ar-

Research is likely to reveal techniques for successfully "improving" or
"enhancing" non-genetic traits such as strength or beauty.

ticle, the revolution in human genetics will extend beyond identifying
and preventing or treating genetic
ailments. The same techniques that
respond to genetic disorders also will
be applicable to non-disease traits.
Currently much work is underway to
identify the proteins that genes
"code for" in order to correct protein imbalances that produce illness.
The same process can be used to produce drugs that affect any other protein-dependent characteristic, not
just those that are regarded as illnesses. Similarly, gene transfer technology that will be used to remove
errant DNA or to install healthy DNA
also will be able to manipulate DNA
for other purposes.
At this point it is not known how
many non-disease human characteristics are, at least in part, inherited.
But research already has confirmed
that certain traits that many would
consider fundamental to personal
well-being and social success-traits
such as beauty, strength, and intelligence-are substantially influenced
by a person's genetic endowmentY
Many of these traits probably are
"multifactorial"-that is, the result
of the interaction of numerous individual genes and with environmental
factors. Altering the function of one
of these genes may have undesired effects on other physical or mental
characteristics. Eventually, however,
research is likely to reveal techniques
for successfully "improving" or "en-

It is a truism that parents typically
want to give their children the best
chance in life that they can. Indeed,
some parents seem to know no
bounds, such as the mother who was
sentenced to 10 years in jail for plotting to murder a popular junior high
school cheerleader so that her
daughter could fill the vacancy on
the cheerleading squad. 14
Parents not only put their children
in private schools and pay for piano
lessons; increasingly they turn to
medical interventions to give their
kids a perceived advantage over others. An endocrinologist reports being
asked by parents to prescribe human
growth hormone to their child so
that she could gain the two inches in

height needed to make her an irresistible candidate for college volleyball scholarships. 15 A recent report in
the press says that a growing number
of parents in California and other
Sun belt states are giving their daughters breast implants as high school
graduation presents. 16
The question that the courts will
be forced to struggle with is whether
there is a legal limit to the authority
of parents to manipulate the genetic
characteristics of their children. One
way this issue will arise is when parents give their children drugs to improve performance in sports competitions or mental achievement tests.
Even if these practices are not expressly forbidden by law or by the private legal rules governing the activity,
the possible health risks may subject
parents to charges of child endangerment. Similar doubts about parental
fitness would arise if parents agreed
to let their children participate in experiments to determine the safety
and efficacy of enhancement prod-

13. See, e.g., Bouchard, Genes, Environment, and
Personality, 264 SciENCE 1700 (1994) (stating that
"two-thirds of the reliable variance in measured
personality traits is due to genetic influence").
See also Finkel et. al., Heritability of Cognitive Abilities in Adult Twins: Comparison of lvlinnesota and
Swedish Data, 25 BEHAVIOR GENETICS 421, 430
(1995) (estimating that cognition in early and
middle adulthood has a heritability factor of approximately 81%); Petri!! et. al., The Geneti:ccztndEnvironmental Variance Underlying ElementaT)• Cognitive Tasks, 25 BEHAVIOR GENETICS 199 (i995)

(demonstrating that elementary cognitive tasks
display genetic effects).
14. See, C/zeerleade·r Case Sentence, N.Y. Times,
Sept. 10, 1996, at A23 ("[a] woman who offered
her diamond earrings in a murder-for-hire plot
aimed at getting her daughter on the junior high
cheerleading squad was sentenced to 10 years in
prison today").
15. Personal communication from Thomas H.
Murray, President, The Hastings Center.
16. Cleveland Plain Dealer, April 23, 1999, at
19-A.
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hancing" a person's non-disease genetic traits. This raises a host of problems that will begin to confront the
judicial system in the next century. I
want to discuss a few of the most challenging issues here.

Parental authority

ucts. In none of these cases, moreover, would the parents be able to
hide behind the shield of religious
freedom, as they often can now in
making questionable treatment decisions for their children. 17
Yet parents are not likely to wait
until a child is born in order to attempt to influence its genetic inheritance, including its inheritance of
non-disease characteristics. The availability of genetic tests will open the
door to several types of genetic enhancements that will take place
much earlier. The first of these is preconception enhancement, in which decisions about whether or not and with
whom to conceive a child
would be made on the basis of pre-conception genetic testing. Just as some
people now test themselves to avoid conceiving
a child with another person who is a "carrier" for
a recessive genetic disorder, prospective mates in
the future could test
themselves to ascertain if
they were likely to produce offspring who were "superior"
in terms of non-disease characteristics. Unsatisfactory results would lead
to decisions not to marry or not to
conceive, at least not without employing genetic manipulations to improve the genetic profile of the offspring.
Another form of genetic enhancement stemming from genetic testing
would be enhancement via selective abortion. Fetuses would be tested in utero
and those that did not match up to
parents' expectations would be
aborted, just as fetuses currently
might be aborted if they tested positive for abnormalities or incurable

diseases. An alternative to selective
abortion would be emln~'I'Q.selection for
enhancement, which combines genetic
testing with in vitro fertilization so
that embryos were tested before they
were implanted in the womb, and
only embryos with advantageous
characteristics were implanted.
Finally, and most dramatically, an
early-stage embryo might be genetically altered prior to implantation,
with DNA inserted or deleted to produce desired traits in the resulting
child. If performed at an earlyenough stage of embryonic development, the alteration would affect all
subsequent fetal cells, including

germ cells-that is, those that became
eggs or sperm. This would result in
germ-cell enhancement, in which genetic
changes would be passed on when the
enhanced individual reproduced.
Some of these actions undoubtedly
lie within the realm of constitutionally protected personal autonomy
and reproductive freedom, for example, the decision about whom to
marry based on genetic testing.
Other activities may not be so clearly
protected. Some scholars argue, for
example, that the state has a legitimate interest in regulating selective
abortion and embryo selection when
performed for enhancement pur-

17. See, e.g., Massie, The Religion Clauses and Pa·
rental Health Care Decision making for Children: Sug·
gestions for a New Approach, 21 HAsTINGS CoNSTL. L.
Q. 725 (1994).
18. See, e.g., Malinowski, Coming Into Being:
Law, Ethics, and the Practice of Prenatal Genetic
Screening, 45 HASTINGS L.j. 1435, 1450 (1994).
Cited in Robertson, Genetic Selection of Offspring
Characteristics, 76 B.U. L. REv. 421 (1996).
19. See generally Agar, Designing Babies: Morally
Permissible Ways to j\!Jodi./)' the Human Genome, 9
BIOETHICs 1·15 (1995); Elliot, Identity and the Ethics
of Gene Therapy, 7 BIOETHJCS 27-40 (1993); Kahn,

Genetic Harm: Bitten by the Body that Keeps You?, 5
BWETHICS 289-309 ( 1991); Persoson, Genetic
Therapy, Identity and the Person-Regarding Reasons, 9
BIOETHJCS 18-31 (1995); Zohar, Prospects for "Gene
Therapy "-Can a Person Benefit from Being Altered?,
5 BJOETHICS 275-288 (1991); Dwyer, Parents' Reli·
gion and Children's Welfare: Debunking the Doctrine
of Parents' Rights, 82 CAL. L. REv. 1371, 1446-1447
(1994), Cited in Robertson, supra n. 18.
20. For a fuller discussion of wealth-based ac·
cess to genetic enhancement, see Mehlman and
Botkin, ACCESS TO THE GENOME: THE CHALLENGE TO
EQUALITY (Georgetown University Press, 1999).

poses, even though parents have a
constitutional right to abort and perhaps even to select embryos for implantation when they do so for medical reasons, such as to avoid the birth
of a child with a genetic illness. 18
An interesting question is what the
state's interest would be in regulating
parental access to genetic enhancement for their children. The interest
might be the need to prevent harm
to the future child, similar to the justification offered for government actions to prohibit illegal drug use by
pregnant women that threatens the
health of the fetus. Yet assuming that
genetic enhancement techniques are
developed that do not
physically harm the child,
the state would have to
rely on less tangible forms
of harm. Some commentators have suggested that
genetic enhancement interferes with the child's
right to genetic autonomy-that children
deserve a genetic endowment free from parental
manipulation. 19 Yet parents invariably manipulate their
children's futures once they are
born. What is so different about doing so before the child is born, assuming that the manipulation is beneficial to the child?
A stronger basis for upholding governmental restrictions on parents'
ability genetically to enhance their
children might be the negative impact of genetic enhancement on our
democratic political system. Genetic
enhancement is likely to be accessible only to wealthier families, since
it is not likely to be covered by public
or private health insurance plans. 20
Assuming that genetic enhancement is effective at improving personal traits that correlate with social
success, those who can afford to purchase genetic enhancements will
gain significant social advantages,
and the ability to genetically enhance
their children, particularly the use of
germ line enhancements that are
passed on to succeeding generations,
could create a "genobility" with an
unassailable lock on power and privi-

Those who can afford
to purchase genetic
enhancements v,rill gain
significant social advantages.
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lege. The threat that this poses is tions, such as the private rules that
more than just a philosophical objec- prohibit the use of performance-ention to social inequality; it is a threat har1Cing drugs in the Olympics or
to the fundamental belief in equality other sports competitions, or the seof opportunity that sustains our po- curities laws that ban trading on inlitical system in the face of frank dis- side information. In other situations,
parities of wealth, privilege, and the law requires the advantaged party
power. If, as the result of wealth~ to disgorge the advantage to the benbased access to genetic enhance- efit of the other party, such as by rement, society becomes divided into quiring disclosure of information to
genetic haves (the enhanced) and correct a material mistake by the
have no ts (the unenhanced), the other party to a contract negotiapossibility of upward social mobility tion. 22 The doctrine of unconscionawill be seen as illusory. In the face of bility allows courts to void a contract if
such a hardened class structure, the the outcome, resulting from an imunderclass is likely to rebel, in turn balance of market power or informaprovoking anti-democratic repres- tion between the parties, seems too
sion by the genetic upper class. Even unfair. 23 In still other contexts, the law
if a stable political system eventually eliminates the arm's length nature of
emerged, it would not resemble the transaction, making the advanWestern liberal democracy.
taged party a fiduciary who must act
Avoiding such a fate is a sufficiently in the other party's best interests. 2 ~
compelling state interest to justify a Yet in some instances, the rules seem
wide range of restrictions on parental blind to the potential unfairness. SAT
enhancement of offspring, as well as scores for college applicants are not
substantial limitations on the free- weighted in terms of IQ, despite the
dom of adults to purchase enhance- obvious unfairness. Shorter basketments for themselves. For example, ball players are not allowed to shoot
the law might legitimately ban the from stepladders.
use of germ line genetic enhanceThese varying responses of the law
ments, and it might allow persons to make it difficult to predict how
purchase somatic enhancements for courts will respond to the unfairness
themselves only on condition that created by genetic enhancements.
they make an enforceable commit- Yet it seems certain that, at least in
ment to employ their advantages some cases, courts will feel comfor social and not just personal pelled to level the playing field.
benefit, in much the same way that
we license professionals such as Negligence
doctors and lawyers.~ 1
A final illustration of the potential
impact of genetic enhancement on
Unfairness
the courts is its effect on the standard
No matter what approach society of care to which people are expected
takes to genetic enhancements, some to adhere when they create risks of
individuals undoubtedly will obtain injury to one another. Should an enthem-whether by becoming li- hanced person be held to the stancensed or by purchasing them in an dard of care of an ordinary reasonunregulated free market or through able person, or to the standard of an
black or gray markets in a highly re- enhanced person? An obvious anstricted system of access. These indi- swer might be that, if enhanced perviduals will gain significant advan- sons ought to be better at avoiding
tages over unenhanced persons with accidents than unenhanced persons,
whom they interact or compete. How then the enhanced persons should
should the law respond to the poten- be held to an enhanced person's
tial unfairness of these interactions?
standard of care. In other words, they
The law is no stranger to imbal- should not escape liability by showing
ances between interacting parties. In that they met a reasonable person's
certain situations, courts are called standard of care when, by virtue of
upon to enforce bans on such interac- their enhancements, they ought to
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have done better.
Automobile drivers with enhanced
vision who run over children, for example, should not be heard to argue
that, although they could have seen
the child in enough time to stop, they
were not negligent since an ordinary
person would not have been able to
stop in time. This seems to be the answer that the Restatement of Torts
would give, since section 289 states
that, at least in regard to appreciating
the risk created by one's behavior, an
actor must use "such superior attention, perception, memory, knowledge, intelligence, and judgment as
the actor himself has."
A good argument can be made,
however, that when it comes to reducing the costs of accidents, we indeed
ought to hold an enhanced person to
the lower standard of an ordinary
"reasonable" person. The reason is
that by not penalizing them with an
enhanced person's standard, we will
encourage more people to enhance
themselves, thereby reducing accidents simply because, as a result of
their better vision or reflexes or intelligence, enhanced people are better
at avoiding them.

A different society
The broad scope of the issues mentioned in this article-from automobile accidents to altering the genes of
future generations-demonstrates
the breadth of the impact that gene
therapy and related technologies will
have on our society. They will challenge conventional notions of illness,
insurance, personal worth, and desert, and the limits of governmental
control over individual freedom and
parental discretion. Ultimately the
courts will decide how far the law can
go in response to these challenges.
One thing is certain: the society that
emerges will look very different from
our own. ~14)
21. For a more complete discussion of these societal responses, see Mehlman, The Law of r1bove
Averages: Leveling the New Genetic Enhancement Playing Field, IowAL. REv. (forthcoming).
22. See RESTATEMENT (SECOND) OF CONTRACTS

§161 (d) (1981).

23. See

RESTATEMENT (SECOND) OF CONTRACTS

§153 (1981).
24. See REsTATEMENT
(1957).

(SECOND) OF TRUSTS

§170

